HomeNewsBusinessMarketsGold eases, but holds near seven-year peak as virus impact weighs

Gold eases, but holds near seven-year peak as virus impact weighs

Spot gold was down 0.2% at $1,608.96 per ounce, as of 0550 GMT. U.S. gold futures were flat at $1,611.90.

February 20, 2020 / 12:51 IST
Story continues below Advertisement

Gold prices dipped on Thursday after China unveiled measures to soften the economic impact of the coronavirus outbreak, but the metal held close to a nearly seven-year peak scaled in the previous session as concerns over the epidemic prevailed.

Spot gold was down 0.2% at $1,608.96 per ounce, as of 0550 GMT. U.S. gold futures were flat at $1,611.90.

Story continues below Advertisement

"It seems to be a bit more corrective mostly because ... it's not just in gold that we are seeing a bit of a walk-back in risk-off dynamics, but across a variety of assets," said DailyFx currency strategist Ilya Spivak.

China's central Hubei province had 349 new confirmed cases of coronavirus on Wednesday, the province's health commission said, down from 1,693 a day earlier and the lowest since Jan. 25, although it was accompanied by a change in methodology.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show